Log In
Print
BCIQ
Print
Print this Print this
 

Cytorex EBV (Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTLs)) (CMD-003)

  Manage Alerts
Collapse Summary General Information
Company Cell Medica Ltd.
DescriptionEBV-specific cytotoxic T lymphocytes (CTLs)
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase II
Standard Indication Cancer (unspecified)
Indication DetailsTreat aggressive Epstein-Barr virus (EBV) positive extranodal NK/T-cell lymphoma; Treat or prevent Epstein-Barr virus (EBV)-positive lymphoproliferative disease in patients undergoing hematopoietic stem cell transplantation
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today